NYSE · MMMHealthcareSurgical Instruments

3M financials

$168.49−0.58%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
FY23
Dec 31
FY22
Dec 31
FY21
Dec 31
FY20
Dec 31
FY19
Dec 31
FY18
Dec 31
FY17
Dec 31
FY16
Dec 31
Revenue$24.95B$24.57B$24.61B$26.16B$35.35B$32.18B$32.14B$32.77B$31.66B$30.11B
Gross profit$9.96B$10.13B$9.63B$10.31B$16.56B$15.58B$15.00B$16.08B$15.60B$14.99B
Gross margin39.9%41.2%39.1%39.4%46.8%48.4%46.7%49.1%49.3%49.8%
Operating income$4.79B$4.82B-$10.72B$1.65B$7.37B$6.77B$6.06B$6.66B$7.11B$6.92B
Net income$3.25B$4.17B-$7.00B$5.78B$5.92B$5.45B$4.52B$5.35B$4.86B$5.05B
Net margin13.0%17.0%−28.4%22.1%16.7%16.9%14.1%16.3%15.3%16.8%
Diluted EPS$6.00$7.55$-12.63$10.18$10.12$9.36$7.72$8.89$7.93$8.16
EBITDA$6.10B$6.18B-$8.74B$3.75B$9.28B$8.68B$7.65B$8.15B$8.65B$8.39B
Operating cash flow$2.31B$1.82B$6.68B$5.59B$7.45B$8.11B$7.07B$6.44B$6.24B$6.66B
Free cash flow$1.40B$638.0M$5.07B$3.84B$5.85B$6.61B$5.37B$4.86B$4.87B$5.24B
Diluted shares541.3M552.4M553.9M567.6M585.3M582.2M585.1M602.0M612.7M618.7M

Balance sheet

Period endDec 31Dec 31Dec 31Dec 31Dec 31Dec 31
Cash & equivalents$5.24B$5.60B$5.74B$3.65B$4.56B$4.63B
Short-term investments$698.0M$2.13B$50.0M$238.0M$201.0M$404.0M
Total debt$12.60B$13.04B$16.04B$15.94B$17.36B$18.80B
Total assets$37.73B$39.87B$50.58B$46.45B$47.07B$47.34B
Total liabilities$32.99B$35.97B$45.71B$31.68B$31.95B$34.41B
Shareholders' equity$4.75B$3.89B$4.87B$14.77B$15.12B$12.93B

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology